Latest News and Press Releases
Want to stay updated on the latest news?
-
First-ever use of Ebenbuild’s Twinhale technology in idiopathic pulmonary fibrosis lung modelsTrial results published in Nature Communications Munich, Germany – April 9, 2025 -- Ebenbuild, a company...
-
New York, United States, March 06, 2025 (GLOBE NEWSWIRE) -- Idiopathic pulmonary fibrosis is a progressive, chronic lung disease that affects people aged 50 to 70. Breathlessness and a dry,...
-
New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
-
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...
-
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Fibrosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
-
Surrozen Provides First Quarter 2024 Financial Results and Business Update
-
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...
-
PROVIDENCE, Rhode Island, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 22, 2023, it received a notice from The Nasdaq Stock Market...
-
Seattle, April 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary diseases, today reported...
-
NEWARK, Del, March 28, 2023 (GLOBE NEWSWIRE) -- The global spirometer market size is set to reach US$ 616 million in 2023. Overall sales of spirometer are likely to surge at 5.4% CAGR, taking the...